Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Experimental Neoplasms
go back to main search page
Accession:DOID:9002170 term browser browse the term
Definition:Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Synonyms:exact_synonym: Experimental Neoplasm
 primary_id: MESH:D009374
For additional species annotation, visit the Alliance of Genome Resources.



show annotations for term's descendants           Sort by:
 
Experimental Neoplasms term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19878872 NCBI chr 9:53,118,462...53,262,092
Ensembl chr 9:53,119,641...53,261,307
JBrowse link
G AHR aryl hydrocarbon receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9496914 NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
JBrowse link
G ARL6IP5 ADP ribosylation factor like GTPase 6 interacting protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29545876 NCBI chr20:22,632,613...22,653,894
Ensembl chr20:22,633,808...22,653,870
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator ISO CTD Direct Evidence: marker/mechanism CTD PMID:9496914 Ensembl chr17:59,941,353...60,010,867
Ensembl chr17:59,941,353...60,010,867
JBrowse link
G AXL AXL receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26206560 NCBI chr 1:112,699,679...112,727,434
Ensembl chr 1:112,700,365...112,726,960
JBrowse link
G BCR BCR activator of RhoGEF and GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19878872 NCBI chr26:27,856,280...27,980,923
Ensembl chr26:27,856,082...27,978,318
JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr16:8,222,909...8,318,179
Ensembl chr16:8,222,907...8,317,906
JBrowse link
G BSG basigin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21165561 NCBI chr20:57,942,703...57,951,089
Ensembl chr20:57,943,276...57,951,061
JBrowse link
G CCND1 cyclin D1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr18:48,501,905...48,509,684
Ensembl chr18:48,501,899...48,516,005
JBrowse link
G CDH1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27224422 NCBI chr 5:80,757,508...80,834,878
Ensembl chr 5:80,757,508...80,834,878
JBrowse link
G CDK4 cyclin dependent kinase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr10:1,812,864...1,815,815
Ensembl chr10:1,812,886...1,815,789
JBrowse link
G CTCF CCCTC-binding factor ISO human breast cancer cells in mouse model RGD PMID:21896759 RGD:151356745 NCBI chr 5:81,808,512...81,863,811
Ensembl chr 5:81,809,393...81,858,655
JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 treatment ISO human cancer cells in mouse model RGD PMID:26719540 RGD:11520844 NCBI chr12:653,800...671,190
Ensembl chr12:653,807...670,543
JBrowse link
G ENO2 enolase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22613180 NCBI chr27:38,120,404...38,128,543
Ensembl chr27:38,119,413...38,129,182
JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14612517 NCBI chr 9:22,760,373...22,785,367
Ensembl chr 9:22,759,256...22,785,294
JBrowse link
G ERGIC3 ERGIC and golgi 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27588471 NCBI chr24:24,494,494...24,508,114
Ensembl chr24:24,494,524...24,508,113
JBrowse link
G ESRRA estrogen related receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:34524571 NCBI chr18:52,755,547...52,762,938
Ensembl chr18:52,756,344...52,763,355
JBrowse link
G F2R coagulation factor II thrombin receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:17374729 NCBI chr 3:29,870,159...29,889,837
Ensembl chr 3:29,872,155...29,889,687
JBrowse link
G HDAC6 histone deacetylase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34524571 NCBI chr  X:42,004,268...42,024,726
Ensembl chr  X:42,004,591...42,024,427
JBrowse link
G HGF hepatocyte growth factor ISO CTD Direct Evidence: therapeutic CTD PMID:21273587 NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:28574600 NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:3433577 PMID:11552296 PMID:26558449 NCBI chr18:25,642,844...25,644,717
Ensembl chr18:25,642,844...25,644,717
JBrowse link
G HRH2 histamine receptor H2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:6224980 NCBI chr 4:37,333,843...37,407,146
Ensembl chr 4:37,275,852...37,386,072
JBrowse link
G IFNB1 interferon beta 1 ISO CTD Direct Evidence: therapeutic CTD PMID:2297754 NCBI chr11:40,668,295...40,668,855
Ensembl chr11:40,668,295...40,668,855
JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: therapeutic CTD PMID:15711825 NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
JBrowse link
G IL12A interleukin 12A ISO CTD Direct Evidence: therapeutic CTD PMID:17332360 NCBI chr34:26,125,529...26,133,546
Ensembl chr34:26,124,770...26,133,550
JBrowse link
G IL12B interleukin 12B ISO CTD Direct Evidence: therapeutic CTD PMID:17332360 NCBI chr 4:51,178,637...51,194,606
Ensembl chr 4:51,183,568...51,193,228
JBrowse link
G IL2 interleukin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:1949363 PMID:3495671 PMID:22306178 NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
JBrowse link
G ITGAV integrin subunit alpha V treatment ISO human cells in rat model RGD PMID:20841470 RGD:152998949 NCBI chr36:28,815,215...28,890,569
Ensembl chr36:28,804,013...28,887,430
JBrowse link
G KIF11 kinesin family member 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17974955 NCBI chr28:6,982,296...7,034,380
Ensembl chr28:6,982,146...7,033,104
JBrowse link
G KRAS KRAS proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9205081 PMID:10813127 PMID:21311774 PMID:25851810 PMID:26390243 NCBI chr27:22,261,753...22,296,704
Ensembl chr27:22,257,941...22,293,369
JBrowse link
G LDHA lactate dehydrogenase A ISO RGD PMID:11085542 RGD:1600281 NCBI chr21:40,829,844...40,840,947 JBrowse link
G LECT2 leukocyte cell derived chemotaxin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr11:23,864,062...23,873,720
Ensembl chr11:23,864,064...23,886,226
JBrowse link
G LOC100687127 thioredoxin-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:28574600 NCBI chr  X:82,986,288...82,986,753 JBrowse link
G LOC106558903 glycine-rich cell wall structural protein 1-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:34652879 NCBI chr 6:38,183,097...38,194,899 JBrowse link
G MAPK7 mitogen-activated protein kinase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29507229 NCBI chr 5:40,831,949...40,836,990
Ensembl chr 5:40,831,947...40,836,505
JBrowse link
G MIR143 microRNA mir-143 ISO CTD Direct Evidence: therapeutic CTD PMID:28736328 PMID:31152816 NCBI chr 4:59,534,535...59,534,589
Ensembl chr 4:59,534,535...59,534,594
JBrowse link
G MIR323 microRNA mir-323 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr 8:69,257,494...69,257,549
Ensembl chr 8:69,257,479...69,257,564
JBrowse link
G MIR34B microRNA mir-34b ISO CTD Direct Evidence: therapeutic CTD PMID:22113133 NCBI chr 5:21,558,685...21,558,768
Ensembl chr 5:21,558,685...21,558,768
JBrowse link
G MIR369 microRNA mir-369 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr 8:69,294,073...69,294,128 JBrowse link
G MIR370 microRNA mir-370 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr 8:69,132,786...69,132,864
Ensembl chr 8:69,132,786...69,132,864
JBrowse link
G MIR381 microRNA mir-381 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr 8:69,274,983...69,275,057 JBrowse link
G MIR433 microRNA mir-433 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr 8:69,103,838...69,103,911
Ensembl chr 8:69,103,820...69,103,928
JBrowse link
G MIR487B microRNA mir-487b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr 8:69,275,496...69,275,553
Ensembl chr 8:69,275,473...69,275,576
JBrowse link
G MIR506 microRNA mir-506 ISO CTD Direct Evidence: therapeutic CTD PMID:21726609 NCBI chr  X:115,652,383...115,652,517
Ensembl chr  X:115,652,383...115,652,517
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:9496914 PMID:21034357 NCBI chr 5:79,979,593...79,990,875
Ensembl chr 5:79,978,865...79,989,860
JBrowse link
G NRAS NRAS proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9205081 NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
JBrowse link
G PARG poly(ADP-ribose) glycohydrolase ISO CTD Direct Evidence: therapeutic CTD PMID:33044785 NCBI chr28:1,651,698...1,767,210
Ensembl chr28:1,652,670...1,766,895
JBrowse link
G PCNA proliferating cell nuclear antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr24:16,478,774...16,485,992
Ensembl chr24:16,478,769...16,484,992
JBrowse link
G POLR1H RNA polymerase I subunit H ISO CTD Direct Evidence: marker/mechanism CTD PMID:16609701 NCBI chr35:26,285,520...26,288,550
Ensembl chr35:26,285,538...26,288,534
JBrowse link
G PRL prolactin treatment ISO RGD PMID:26983879 RGD:152177690 NCBI chr35:20,673,830...20,683,824
Ensembl chr35:20,673,839...20,683,824
JBrowse link
G PRNP prion protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:21265952 NCBI chr24:16,845,224...16,862,319
Ensembl chr24:16,846,207...16,859,815
JBrowse link
G PUF60 poly(U) binding splicing factor 60 ISO CTD Direct Evidence: therapeutic CTD PMID:21435101 NCBI chr13:37,375,781...37,387,969
Ensembl chr13:37,375,651...37,387,875
JBrowse link
G RB1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27137931 NCBI chr22:3,061,621...3,204,625
Ensembl chr22:3,063,239...3,257,726
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 disease_progression ISO RGD PMID:24244675 RGD:152995458 NCBI chr 4:69,903,393...70,013,168
Ensembl chr 4:69,936,379...70,010,566
JBrowse link
G SPARC secreted protein acidic and cysteine rich ISO CTD Direct Evidence: therapeutic CTD PMID:20164124 NCBI chr 4:57,659,541...57,682,147
Ensembl chr 4:57,659,650...57,681,711
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:21852811 NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29507229 NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
JBrowse link
G STIM1 stromal interaction molecule 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27863410 NCBI chr21:26,394,592...26,594,764
Ensembl chr21:26,394,811...26,593,375
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: therapeutic CTD PMID:1674182 PMID:3361654 PMID:12627504 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
JBrowse link
G TNFSF10 TNF superfamily member 10 ISO CTD Direct Evidence: therapeutic CTD PMID:17767197 PMID:24345465 NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060
JBrowse link
G TOB1 transducer of ERBB2, 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12756225 NCBI chr 9:26,736,805...26,741,119
Ensembl chr 9:26,736,675...26,740,177
Ensembl chr 9:26,736,675...26,740,177
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12756225 PMID:27137931 NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
JBrowse link
G TP63 tumor protein p63 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25739959 NCBI chr34:21,766,861...21,985,095
Ensembl chr34:21,766,496...21,983,046
JBrowse link
G TRIM47 tripartite motif containing 47 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31981573 NCBI chr 9:4,718,806...4,731,121
Ensembl chr 9:4,726,249...4,730,790
JBrowse link
G URI1 URI1 prefoldin like chaperone ISO CTD Direct Evidence: marker/mechanism CTD PMID:21397856 NCBI chr 1:121,528,706...121,612,200
Ensembl chr 1:121,530,203...121,614,909
JBrowse link
G VEGFA vascular endothelial growth factor A ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:20376344 PMID:20932960 PMID:28574600 NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
JBrowse link
Avian Sarcoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G RHOB ras homolog family member B ISO RGD PMID:1710770 RGD:704375 NCBI chr17:15,438,744...15,439,793
Ensembl chr17:15,439,143...15,441,136
JBrowse link
Carcinoma, Lewis Lung term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C3 complement C3 treatment ISO RGD PMID:16947020 RGD:7401280 NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
JBrowse link
G COQ7 coenzyme Q7, hydroxylase susceptibility ISO RGD PMID:23166727 RGD:10402105 NCBI chr 6:25,912,936...25,922,123
Ensembl chr 6:25,912,954...25,929,655
JBrowse link
G CSF1R colony stimulating factor 1 receptor ameliorates ISO mouse cell line in a mouse model RGD PMID:20008303 RGD:150524291 NCBI chr 4:58,980,699...59,010,683
Ensembl chr 4:58,980,788...59,010,510
JBrowse link
G IL18 interleukin 18 treatment ISO RGD PMID:16767432 RGD:8655941 NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
JBrowse link
G IL2 interleukin 2 treatment ISO RGD PMID:9399664 RGD:8663451 NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
JBrowse link
G IRAK3 interleukin 1 receptor associated kinase 3 ISO RGD PMID:21278795 RGD:36049796 NCBI chr10:8,683,541...8,730,757
Ensembl chr10:8,684,242...8,729,268
JBrowse link
G JAM3 junctional adhesion molecule 3 ISO RGD PMID:15994945 RGD:7488936 NCBI chr 5:1,082,619...1,165,188
Ensembl chr 5:1,084,560...1,165,121
JBrowse link
G LECT2 leukocyte cell derived chemotaxin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr11:23,864,062...23,873,720
Ensembl chr11:23,864,064...23,886,226
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 ameliorates ISO mouse cell line in a mouse model RGD PMID:29907597 RGD:151665504 NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor treatment ISO mouse cell line in a mouse model RGD PMID:26111447 RGD:150521531 NCBI chr23:7,901,578...7,905,274
Ensembl chr23:7,901,250...7,904,534
JBrowse link
G TXNRD1 thioredoxin reductase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16565519 NCBI chr10:33,904,065...34,021,549
Ensembl chr10:33,886,343...34,021,696
JBrowse link
Ehrlich tumor carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CD40 CD40 molecule treatment ISO RGD PMID:19269163 RGD:11352683 NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
JBrowse link
G CD40LG CD40 ligand treatment ISO RGD PMID:19269163 RGD:11352683 NCBI chr  X:107,001,421...107,023,007
Ensembl chr  X:107,010,890...107,023,006
JBrowse link
G CEACAM20 CEA cell adhesion molecule 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34605108 NCBI chr 1:110,744,921...110,829,413
Ensembl chr 1:110,805,089...110,827,606
JBrowse link
Experimental Leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CBL Cbl proto-oncogene treatment ISO RGD PMID:20890046 RGD:11038805 NCBI chr 5:14,600,409...14,676,974
Ensembl chr 5:14,607,013...14,676,956
JBrowse link
G CBX7 chromobox 7 ISO RGD PMID:25434821 RGD:11352713 NCBI chr10:25,876,022...25,896,284
Ensembl chr10:25,876,016...25,893,501
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO RGD PMID:10090949 RGD:11251764 NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379
JBrowse link
G FGFR1 fibroblast growth factor receptor 1 treatment ISO RGD PMID:22781593 RGD:11352669 NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261
JBrowse link
G IL1A interleukin 1 alpha treatment ISO RGD PMID:2117483 RGD:11051972 NCBI chr17:36,969,581...36,979,445
Ensembl chr17:36,970,573...36,979,435
JBrowse link
G LAT2 linker for activation of T cells family member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32587277 NCBI chr 6:6,160,939...6,175,271
Ensembl chr 6:6,161,542...6,173,294
JBrowse link
G NRAS NRAS proto-oncogene, GTPase induced ISO DNA:transversion mutation, loss of heterozygosity:cds: RGD PMID:9142215 RGD:11535063 NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
JBrowse link
G PTPN11 protein tyrosine phosphatase non-receptor type 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32417439 NCBI chr26:9,989,218...10,072,245
Ensembl chr26:9,989,425...10,067,481
JBrowse link
G RUNX1 RUNX family transcription factor 1 treatment ISO RGD PMID:19236814 RGD:11251683 NCBI chr31:30,170,859...30,420,344
Ensembl chr31:30,170,605...30,420,839
JBrowse link
Experimental Liver Neoplasms term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 ISO RGD PMID:15853769 RGD:1598580 NCBI chr36:13,742,895...13,835,312
Ensembl chr36:13,746,964...13,834,974
JBrowse link
G ADSL adenylosuccinate lyase ISO protein:increased activity:liver (rat) RGD PMID:2937404 RGD:1598766 NCBI chr10:24,813,854...24,832,115 JBrowse link
G AFP alpha fetoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:24012840 PMID:32961231 NCBI chr13:62,182,876...62,203,414
Ensembl chr13:62,053,814...62,294,709
JBrowse link
G AGPS alkylglycerone phosphate synthase ISO RGD PMID:7407223 RGD:1598794 NCBI chr36:21,131,616...21,264,615
Ensembl chr36:21,131,641...21,329,467
JBrowse link
G ALAS2 5'-aminolevulinate synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr  X:46,703,477...46,731,767
Ensembl chr  X:46,703,477...46,723,529
JBrowse link
G APOA4 apolipoprotein A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
JBrowse link
G APOC2 apolipoprotein C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 1:110,504,806...110,506,986
Ensembl chr 1:110,504,815...110,506,961
JBrowse link
G ARID1A AT-rich interaction domain 1A disease_progression ISO RGD PMID:26569409 RGD:11344640 NCBI chr 2:73,331,606...73,401,151
Ensembl chr 2:73,324,852...73,401,102
JBrowse link
G ARRB2 arrestin beta 2 ISO mRNA, protein:increased expression:liver (rat) RGD PMID:21167192 RGD:5509890 NCBI chr 5:31,831,208...31,838,875
Ensembl chr 5:31,829,864...31,839,454
JBrowse link
G ATP7A ATPase copper transporting alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr  X:60,203,336...60,356,525
Ensembl chr  X:60,203,270...60,352,869
JBrowse link
G ATP7B ATPase copper transporting beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr22:162,474...225,599
Ensembl chr22:191,888...225,266
JBrowse link
G B9D2 B9 domain containing 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
JBrowse link
G BAK1 BCL2 antagonist/killer 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr12:2,950,359...2,957,604
Ensembl chr12:2,948,364...2,957,018
JBrowse link
G BBC3 BCL2 binding component 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 1:108,742,793...108,750,832
Ensembl chr 1:108,741,713...108,749,946
JBrowse link
G BCL2 BCL2 apoptosis regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:10426811 PMID:28100771 NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
JBrowse link
G BCL2L1 BCL2 like 1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:10426811 PMID:22414765 PMID:28100771 RGD:11353865 NCBI chr24:21,145,214...21,209,425
Ensembl chr24:21,145,215...21,196,355
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 ISO mRNA, protein:increased expression:liver RGD PMID:18246794 RGD:2293125 NCBI chr 9:2,930,308...2,959,307 JBrowse link
G CA3 carbonic anhydrase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr29:31,935,192...31,945,585
Ensembl chr29:31,935,172...31,980,579
JBrowse link
G CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase ISO protein:increased activity:liver (rat) RGD PMID:13618893 RGD:5132586 NCBI chr17:21,198,839...21,221,897
Ensembl chr17:21,197,826...21,221,635
JBrowse link
G CCL20 C-C motif chemokine ligand 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30603057 NCBI chr25:40,506,385...40,509,903
Ensembl chr25:40,506,753...40,509,709
JBrowse link
G CCNB1 cyclin B1 ISO mRNA:increased expression:liver RGD PMID:17342310 RGD:2315991 NCBI chr 2:54,256,957...54,264,749 JBrowse link
G CCND1 cyclin D1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:17055752 PMID:28100771 RGD:2289139 NCBI chr18:48,501,905...48,509,684
Ensembl chr18:48,501,899...48,516,005
JBrowse link
G CCNDBP1 cyclin D1 binding protein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:16501603 NCBI chr30:10,053,673...10,064,132
Ensembl chr30:10,053,013...10,119,795
JBrowse link
G CCNG1 cyclin G1 ISO RGD PMID:27982046 RGD:151361200 NCBI chr 4:47,800,697...47,808,259
Ensembl chr 4:47,801,575...47,808,211
JBrowse link
G CCNG2 cyclin G2 ISO RGD PMID:27982046 RGD:151361200 NCBI chr32:1,719,325...1,727,769
Ensembl chr32:1,720,156...1,726,842
JBrowse link
G CD40LG CD40 ligand ISO RGD PMID:19035311 RGD:5491179 NCBI chr  X:107,001,421...107,023,007
Ensembl chr  X:107,010,890...107,023,006
JBrowse link
G CD63 CD63 molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr10:126,370...139,301
Ensembl chr10:126,449...129,742
JBrowse link
G CDH1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20118494 PMID:25319454 NCBI chr 5:80,757,508...80,834,878
Ensembl chr 5:80,757,508...80,834,878
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A ISO protein:decreased expression:liver: RGD PMID:8640740 RGD:8662309 NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B disease_progression ISO mRNA:increased expression:liver (rat) RGD PMID:19533683 RGD:2315050 NCBI chr27:33,609,154...33,613,558
Ensembl chr27:33,611,760...33,612,906
JBrowse link
G CDKN1C cyclin dependent kinase inhibitor 1C disease_progression ISO protein:decreased expression:liver (rat)
protein:increased expression:liver (rat)
mRNA:increased expression:liver (rat)
RGD PMID:3965145 PMID:19533683 PMID:26606000 RGD:11354707 RGD:152998958 RGD:2315050 NCBI chr18:46,860,636...46,861,697 JBrowse link
G COPS5 COP9 signalosome subunit 5 ISO protein:increased expression:liver (rat) RGD PMID:26606000 RGD:11354707 NCBI chr29:16,562,234...16,579,082
Ensembl chr29:16,562,234...16,578,847
JBrowse link
G CP ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr23:43,969,297...44,033,226
Ensembl chr23:43,969,435...44,030,369
JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 severity ISO mRNA:decreased expression:liver RGD PMID:3387993 RGD:2303406 NCBI chr37:18,308,164...18,428,487
Ensembl chr37:18,143,986...18,427,697
JBrowse link
G CTNNB1 catenin beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11280770 PMID:20118494 PMID:21147764 NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO mRNA:increased expression:liver RGD PMID:22687991 RGD:7296954 NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11376689 PMID:21147764 NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18056438 NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
JBrowse link
G CYP2F1 cytochrome P450 family 2 subfamily F member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 1:112,973,776...112,986,419
Ensembl chr 1:112,974,847...112,986,123
JBrowse link
G DHODH dihydroorotate dehydrogenase (quinone) ISO protein:increased activity:liver (rat) RGD PMID:6331524 RGD:5132618 NCBI chr 5:77,756,411...77,766,207
Ensembl chr 5:77,756,407...77,774,090
JBrowse link
G DTYMK deoxythymidylate kinase ISO protein:increased activity:tumor (rat) RGD PMID:6244089 RGD:5133686 NCBI chr25:51,520,307...51,535,407
Ensembl chr25:51,520,581...51,526,069
Ensembl chr25:51,520,581...51,526,069
JBrowse link
G ENO2 enolase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:2910524 NCBI chr27:38,120,404...38,128,543
Ensembl chr27:38,119,413...38,129,182
JBrowse link
G EPHX1 epoxide hydrolase 1 ISO RGD PMID:7260898 RGD:11252158 NCBI chr 7:38,964,319...39,004,902
Ensembl chr 7:38,964,338...38,999,238
JBrowse link
G F12 coagulation factor XII ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 4:35,950,642...35,968,137
Ensembl chr 4:35,950,695...35,998,025
JBrowse link
G FAS Fas cell surface death receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:30737368 NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
JBrowse link
G FOXM1 forkhead box M1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15082532 NCBI chr27:41,894,605...41,905,656
Ensembl chr27:41,894,672...41,905,663
JBrowse link
G GJB1 gap junction protein beta 1 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:1336494 PMID:18308698 RGD:7349398 NCBI chr  X:55,565,995...55,575,332
Ensembl chr  X:55,573,808...55,574,659
JBrowse link
G GJB2 gap junction protein beta 2 ISO RGD PMID:1336494 RGD:7349398 NCBI chr25:17,952,851...17,958,289
Ensembl chr25:17,952,851...17,958,289
JBrowse link
G GLUL glutamate-ammonia ligase ISO CTD Direct Evidence: marker/mechanism CTD PMID:20118494 PMID:21147764 NCBI chr 7:15,730,898...15,740,241
Ensembl chr 7:15,730,898...15,740,241
JBrowse link
G GRP gastrin releasing peptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:2910524 NCBI chr 1:16,974,818...16,987,578
Ensembl chr 1:16,975,113...16,987,531
JBrowse link
G GSTP1 glutathione S-transferase pi 1 ISO protein:increased expression:liver (rat)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:2563599 PMID:3124819 PMID:3965145 PMID:7585603 PMID:12016164 More... RGD:152998958 RGD:2317823 NCBI chr18:49,905,161...49,908,182
Ensembl chr18:49,905,161...49,908,182
JBrowse link
G HAT1 histone acetyltransferase 1 ISO protein:increased expression:liver RGD PMID:17182829 RGD:2316578 NCBI chr36:16,310,269...16,378,029
Ensembl chr36:16,310,710...16,378,017
JBrowse link
G HGF hepatocyte growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11896611 NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622 NCBI chr18:25,642,844...25,644,717
Ensembl chr18:25,642,844...25,644,717
JBrowse link
G HTR2C 5-hydroxytryptamine receptor 2C ISO protein:increased expression:brainstem, cerebral cortex RGD PMID:17258772 RGD:1624998 NCBI chr  X:87,342,800...87,641,224
Ensembl chr  X:87,342,792...87,638,579
JBrowse link
G IGF2 insulin like growth factor 2 treatment ISO RGD PMID:22425635 RGD:10402567 NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982
JBrowse link
G IGF2R insulin like growth factor 2 receptor ISO RGD PMID:9652747 PMID:15057872 RGD:2311623 RGD:2311630 NCBI chr 1:49,161,551...49,262,260
Ensembl chr 1:49,161,444...49,262,277
JBrowse link
G IKBKG inhibitor of nuclear factor kappa B kinase regulatory subunit gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:30737368 NCBI chr  X:122,232,052...122,253,499
Ensembl chr  X:122,235,878...122,250,562
JBrowse link
G IL6 interleukin 6 disease_progression ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:blood serum (mouse)
CTD
RGD
PMID:26297436 PMID:26569409 RGD:11344640 NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
JBrowse link
G INSR insulin receptor disease_progression ISO associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat) RGD PMID:15520221 RGD:2306052 NCBI chr20:52,017,261...52,136,061
Ensembl chr20:52,021,887...52,136,046
JBrowse link
G JAK2 Janus kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
JBrowse link
G KAT6A lysine acetyltransferase 6A ISO protein:increased expression:liver (rat) RGD PMID:17083329 RGD:2312274 NCBI chr16:23,604,629...23,717,047
Ensembl chr16:23,604,200...23,724,252
JBrowse link
G KDR kinase insert domain receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
JBrowse link
G KRAS KRAS proto-oncogene, GTPase disease_progression ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (rat)
CTD
RGD
PMID:8603461 PMID:19533683 RGD:2315050 NCBI chr27:22,261,753...22,296,704
Ensembl chr27:22,257,941...22,293,369
JBrowse link
G MAP2K1 mitogen-activated protein kinase kinase 1 ISO associated with Diabetes Mellitus, Experimental;protein:increased expression:liver RGD PMID:15520221 RGD:2306052 NCBI chr30:30,683,192...30,760,479
Ensembl chr30:30,683,107...30,760,479
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027
JBrowse link
G MFGE8 milk fat globule EGF and factor V/VIII domain containing ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 3:52,054,243...52,064,423
Ensembl chr 3:52,054,831...52,080,240
JBrowse link
G MIR10A microRNA mir-10a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 9:24,842,171...24,842,233
Ensembl chr 9:24,842,145...24,842,248
JBrowse link
G MIR125A microRNA mir-125a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:105,400,273...105,400,332
Ensembl chr 1:105,400,270...105,400,337
JBrowse link
G MIR145 microRNA mir-145 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:59,533,128...59,533,210
Ensembl chr 4:59,533,128...59,533,210
JBrowse link
G MIR151 microRNA mir-151 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr13:35,353,689...35,353,744
Ensembl chr13:35,353,689...35,353,744
JBrowse link
G MIR181C microRNA mir-181c ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr20:48,593,343...48,593,403
Ensembl chr20:48,593,325...48,593,421
JBrowse link
G MIR183 microRNA mir-183 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr14:7,068,542...7,068,603
Ensembl chr14:7,068,519...7,068,625
JBrowse link
G MIR186 microRNA mir-186 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:74,881,615...74,881,675
Ensembl chr 6:74,881,601...74,881,686
JBrowse link
G MIR18A microRNA mir-18a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr22:42,478,138...42,478,229
Ensembl chr22:42,478,138...42,478,229
JBrowse link
G MIR195 microRNA mir-195 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:32,045,450...32,045,510
Ensembl chr 5:32,045,450...32,045,510
JBrowse link
G MIR196B microRNA mir-196b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr14:40,344,005...40,344,062
Ensembl chr14:40,343,993...40,344,077
JBrowse link
G MIR200B microRNA mir-200b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:56,368,400...56,368,479
Ensembl chr 5:56,368,400...56,368,479
JBrowse link
G MIR206 microRNA mir-206 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:19,805,523...19,805,582
Ensembl chr12:19,805,523...19,805,582
JBrowse link
G MIR212 microRNA mir-212 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 9:46,153,913...46,153,974
Ensembl chr 9:46,153,903...46,153,984
JBrowse link
G MIR221 microRNA mir-221 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:39,523,890...39,523,951
Ensembl chr  X:39,523,885...39,523,954
JBrowse link
G MIR26A-1 microRNA mir-26a-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr23:7,747,073...7,747,133
Ensembl chr23:7,747,064...7,747,140
JBrowse link
G MIR26B microRNA mir-26b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr37:25,054,488...25,054,543 JBrowse link
G MIR301A microRNA mir-301a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 9:33,724,572...33,724,655
Ensembl chr 9:33,724,571...33,724,655
JBrowse link
G MIR30A microRNA mir-30a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:33,783,894...33,783,956
Ensembl chr12:33,783,891...33,783,961
JBrowse link
G MIR30B microRNA mir-30b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr13:30,906,038...30,906,097
Ensembl chr13:30,906,038...30,906,097
JBrowse link
G MIR30D microRNA mir-30d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr13:30,910,306...30,910,365
Ensembl chr13:30,910,306...30,910,365
JBrowse link
G MIR30E microRNA mir-30e ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr15:2,283,306...2,283,369
Ensembl chr15:2,283,306...2,283,369
JBrowse link
G MIR331 microRNA mir-331 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr15:35,234,750...35,234,839
Ensembl chr15:35,234,740...35,234,850
JBrowse link
G MIR335 microRNA mir-335 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr14:6,444,861...6,444,918
Ensembl chr14:6,444,847...6,444,932
JBrowse link
G MIR339-1 microRNA mir-339-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:15,853,520...15,853,577
Ensembl chr 6:15,853,520...15,853,577
JBrowse link
G MIR340 microRNA mir-340 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:1,704,582...1,704,673
Ensembl chr11:1,704,582...1,704,673
JBrowse link
G MIR34A microRNA mir-34a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:62,485,832...62,485,897
Ensembl chr 5:62,485,832...62,485,897
JBrowse link
G MIR383 microRNA mir-383 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr16:38,173,722...38,173,783
Ensembl chr16:38,173,693...38,173,803
JBrowse link
G MIR409 microRNA mir-409 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:69,293,782...69,293,835 JBrowse link
G MIR505 microRNA mir-505 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:109,866,448...109,866,523
Ensembl chr  X:109,866,448...109,866,523
JBrowse link
G MIR539 microRNA mir-539 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:69,276,311...69,276,386 JBrowse link
G MIR652 microRNA mir-652 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:83,271,857...83,271,919
Ensembl chr  X:83,271,857...83,271,919
JBrowse link
G MIR671 microRNA mir-671 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr16:15,278,782...15,278,855
Ensembl chr16:15,278,779...15,278,862
JBrowse link
G MIR708 microRNA mir-708 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr21:19,542,577...19,542,645
Ensembl chr21:19,542,577...19,542,645
JBrowse link
G MIR98 microRNA mir-98 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:45,253,693...45,253,772
Ensembl chr  X:45,253,696...45,253,775
JBrowse link
G MIR99B microRNA mir-99b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:105,400,925...105,400,984
Ensembl chr 1:105,400,925...105,400,984
JBrowse link
G MIRLET7D microRNA let-7d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:97,902,012...97,902,136
Ensembl chr 1:97,902,012...97,902,136
JBrowse link
G MIRLET7E microRNA let-7e ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:105,400,740...105,400,806
Ensembl chr 1:105,400,730...105,400,816
JBrowse link
G MMP2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression, increased activity:liver
RGD
CTD
PMID:19528495 PMID:19539802 PMID:30603057 RGD:2325734 RGD:2325736 NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
JBrowse link
G MMP9 matrix metallopeptidase 9 ISO mRNA, protein:increased expression, increased activity:liver RGD PMID:19528495 PMID:19539802 RGD:2325734 RGD:2325736 NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
JBrowse link
G MPEG1 macrophage expressed 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr18:37,530,895...37,535,334
Ensembl chr18:37,531,032...37,533,179
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor ISO mRNA:increased expression:liver (rat)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:3335218 PMID:9079223 PMID:11280770 PMID:18560566 RGD:10059623 NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
JBrowse link
G NOS2 nitric oxide synthase 2 ISO protein:increased expression:liver RGD PMID:10383909 RGD:2325277 NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
JBrowse link
G NOTCH1 notch receptor 1 ISO protein:increased expression:liver RGD PMID:18942116 RGD:2325310 NCBI chr 9:48,975,972...49,018,985
Ensembl chr 9:48,974,757...49,017,277
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 ISO mRNA, protein:increased expression:liver (rat) RGD PMID:27867096 RGD:13442478 NCBI chr 5:79,979,593...79,990,875
Ensembl chr 5:79,978,865...79,989,860
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 susceptibility ISO RGD PMID:17283114 RGD:14701032 NCBI chr15:39,497,313...39,608,120
Ensembl chr15:39,536,290...39,608,116
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17172636 PMID:24769335 PMID:25656644 NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827
JBrowse link
G NRAS NRAS proto-oncogene, GTPase ISO human gene in mouse model RGD PMID:16286660 RGD:14975105 NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
JBrowse link
G PEMT phosphatidylethanolamine N-methyltransferase ISO protein:decreased expression:liver RGD PMID:7929120 RGD:1642378 NCBI chr 5:41,871,685...41,960,831
Ensembl chr 5:41,872,108...41,960,828
JBrowse link
G PLCL1 phospholipase C like 1 (inactive) disease_progression ISO mRNA:increased expression:liver (rat) RGD PMID:19533683 RGD:2315050 NCBI chr37:7,235,403...7,575,429
Ensembl chr37:7,235,424...7,562,708
JBrowse link
G PML PML nuclear body scaffold ISO CTD Direct Evidence: therapeutic CTD PMID:20377131 NCBI chr30:37,232,337...37,278,434
Ensembl chr30:37,232,306...37,277,741
JBrowse link
G PPAT phosphoribosyl pyrophosphate amidotransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:761203 NCBI chr13:48,618,460...48,656,164
Ensembl chr13:48,620,714...48,655,780
JBrowse link
G PPP2CA protein phosphatase 2 catalytic subunit alpha ISO mRNA:increased expression:liver (rat) RGD PMID:2562181 RGD:8693574 NCBI chr11:22,388,327...22,410,052
Ensembl chr11:22,385,257...22,410,052
JBrowse link
G PRDX1 peroxiredoxin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27517622 NCBI chr15:14,834,009...14,855,665
Ensembl chr15:14,838,652...14,862,971
JBrowse link
G PTGR1 prostaglandin reductase 1 ISO protein:increased expression:liver RGD PMID:24853774 RGD:14401713 NCBI chr11:66,191,155...66,212,075
Ensembl chr11:66,191,165...66,209,219
JBrowse link
G RAD51 RAD51 recombinase ISO protein:decreased expression:liver RGD PMID:17219426 RGD:2292638 NCBI chr30:7,842,540...7,877,128
Ensembl chr30:7,842,540...7,877,606
JBrowse link
G RB1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17854601 NCBI chr22:3,061,621...3,204,625
Ensembl chr22:3,063,239...3,257,726
JBrowse link
G RGN regucalcin ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr  X:40,697,292...40,715,491
Ensembl chr  X:40,698,768...40,715,490
JBrowse link
G RIDA reactive intermediate imine deaminase A homolog ISO protein:increased expression:liver (rat) RGD PMID:12939504 RGD:9685719 NCBI chr13:348,744...361,063
Ensembl chr13:348,860...361,522
JBrowse link
G RRAS2 RAS related 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147764 NCBI chr21:37,037,576...37,119,733
Ensembl chr21:37,038,334...37,112,662
JBrowse link
G RRM1 ribonucleotide reductase catalytic subunit M1 ISO RGD PMID:15224347 RGD:2316863 NCBI chr21:26,595,838...26,631,476
Ensembl chr21:26,595,914...26,631,135
JBrowse link
G RXRA retinoid X receptor alpha ISO mRNA, protein:decreased expression:liver RGD PMID:17786350 RGD:1643105 NCBI chr 9:50,525,195...50,575,720
Ensembl chr 9:50,484,567...50,573,119
JBrowse link
G SERPINA1 serpin family A member 1 ISO RGD PMID:10569800 RGD:1626391 NCBI chr 8:63,388,498...63,400,377
Ensembl chr 8:63,376,945...63,398,435
JBrowse link
G SLC31A1 solute carrier family 31 member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr11:67,590,087...67,628,947
Ensembl chr11:67,591,080...67,625,798
JBrowse link
G SLC7A5 solute carrier family 7 member 5 ISO mRNA:increased expression:liver RGD PMID:17498859 RGD:151357003 NCBI chr 5:65,313,105...65,343,858
Ensembl chr 5:65,313,105...65,343,858
JBrowse link
G SOCS1 suppressor of cytokine signaling 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15197228 NCBI chr 6:31,511,003...31,511,995
Ensembl chr 6:31,509,268...31,511,557
JBrowse link
G SOX4 SRY-box transcription factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147764 NCBI chr35:20,098,783...20,101,357
Ensembl chr35:20,099,773...20,101,154
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
JBrowse link
G SQLE squalene epoxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr13:22,994,010...23,018,134
Ensembl chr13:22,993,862...23,017,978
JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26297436 PMID:28100771 NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
JBrowse link
G TEK TEK receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr11:45,278,375...45,377,300
Ensembl chr11:45,278,891...45,409,093
JBrowse link
G TGFA transforming growth factor alpha ISO protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:9079223 PMID:16734725 RGD:2317490 NCBI chr10:68,915,671...68,957,027 JBrowse link
G TK1 thymidine kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 9:2,959,450...2,970,908
Ensembl chr 9:2,959,488...2,971,064
JBrowse link
G TNF tumor necrosis factor treatment
disease_progression
ISO Morris hepatoma
protein:increased expression:blood serum (mouse)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:9063767 PMID:26569409 PMID:28100771 RGD:11344640 RGD:14696818 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10626228 PMID:28100771 NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
JBrowse link
G TSC22D1 TSC22 domain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15833021 PMID:17533171 NCBI chr22:6,375,585...6,506,511
Ensembl chr22:6,375,577...6,505,672
JBrowse link
G VIM vimentin ISO RGD PMID:19199359 RGD:6480440 NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
JBrowse link
G XDH xanthine dehydrogenase ISO protein:decreased expression:liver RGD PMID:3460692 RGD:13210515 NCBI chr17:24,900,708...24,960,748
Ensembl chr17:24,901,447...24,971,935
JBrowse link
Experimental Melanoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACSS1 acyl-CoA synthetase short chain family member 1 treatment ISO RGD PMID:27539851 RGD:13831304 NCBI chr23:1,192,771...1,251,724
Ensembl chr23:1,184,392...1,252,255
JBrowse link
G ACSS2 acyl-CoA synthetase short chain family member 2 treatment ISO RGD PMID:27539851 RGD:13831304 NCBI chr24:23,928,800...23,973,383
Ensembl chr24:23,928,838...23,972,651
JBrowse link
G ANTXR1 ANTXR cell adhesion molecule 1 treatment ISO RGD PMID:19609240 PMID:19622764 RGD:9684925 RGD:9684939 NCBI chr10:67,829,573...68,021,368
Ensembl chr10:67,829,225...68,019,127
JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29179997 PMID:29438700 NCBI chr16:8,222,909...8,318,179
Ensembl chr16:8,222,907...8,317,906
JBrowse link
G CALR calreticulin ISO CTD Direct Evidence: therapeutic CTD PMID:16388313 NCBI chr20:49,251,390...49,255,291
Ensembl chr20:49,251,777...49,255,245
JBrowse link
G CCL20 C-C motif chemokine ligand 20 treatment ISO RGD PMID:14500387 RGD:7483600 NCBI chr25:40,506,385...40,509,903
Ensembl chr25:40,506,753...40,509,709
JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 treatment ISO RGD PMID:24041689 RGD:7411680 NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
JBrowse link
G EGR1 early growth response 1 ISO mRNA, protein:increased expression:salivary gland (mouse) RGD PMID:19517020 RGD:5131885 NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
JBrowse link
G ESR2 estrogen receptor 2 severity ISO RGD PMID:20354658 RGD:8694122 NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
JBrowse link
G HGF hepatocyte growth factor ISO RGD PMID:9823327 RGD:8548620 NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
JBrowse link
G IFNB1 interferon beta 1 ISO CTD Direct Evidence: therapeutic CTD PMID:16417267 NCBI chr11:40,668,295...40,668,855
Ensembl chr11:40,668,295...40,668,855
JBrowse link
G IKBKB inhibitor of nuclear factor kappa B kinase subunit beta ISO RGD PMID:19276165 RGD:7495758 NCBI chr16:23,359,551...23,419,114
Ensembl chr16:23,359,813...23,419,075
JBrowse link
G IL18 interleukin 18 treatment ISO RGD PMID:12230493 PMID:17411412 RGD:8655870 RGD:8655901 NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
JBrowse link
G IL1A interleukin 1 alpha treatment ISO RGD PMID:8061895 RGD:7794735 NCBI chr17:36,969,581...36,979,445
Ensembl chr17:36,970,573...36,979,435
JBrowse link
G IL1B interleukin 1 beta ISO RGD PMID:1966551 RGD:7401226 NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
JBrowse link
G IL2 interleukin 2 ISO RGD PMID:11884028 RGD:8662950 NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
JBrowse link
G KDM1A lysine demethylase 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:29438700 NCBI chr 2:76,313,742...76,375,716
Ensembl chr 2:76,156,434...76,375,632
JBrowse link
G KDM4C lysine demethylase 4C ISO CTD Direct Evidence: marker/mechanism CTD PMID:29438700 NCBI chr11:27,662,764...28,101,432
Ensembl chr11:27,693,536...28,101,801
JBrowse link
G MC1R melanocortin 1 receptor ISO RGD PMID:20126537 RGD:5687319 NCBI chr 5:63,694,296...63,695,249 JBrowse link
G PDCD1 programmed cell death 1 treatment ISO RGD PMID:19208793 RGD:9589070 NCBI chr25:51,606,559...51,618,903
Ensembl chr25:51,608,173...51,618,723
JBrowse link
G PTEN phosphatase and tensin homolog ISO CTD Direct Evidence: marker/mechanism CTD PMID:29179997 NCBI chr26:37,853,148...37,913,176
Ensembl chr26:37,835,661...37,913,176
JBrowse link
G PXN paxillin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18492274 NCBI chr26:16,157,231...16,224,028
Ensembl chr26:16,159,025...16,184,820
JBrowse link
G TERT telomerase reverse transcriptase treatment ISO RGD PMID:19903903 RGD:11038656 NCBI chr34:11,288,622...11,307,790
Ensembl chr34:11,288,622...11,307,951
JBrowse link
Experimental Sarcoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGPS alkylglycerone phosphate synthase ISO RGD PMID:7407223 RGD:1598794 NCBI chr36:21,131,616...21,264,615
Ensembl chr36:21,131,641...21,329,467
JBrowse link
G ALB albumin ISO mRNA,protein:decreased expression:liver,serum: RGD PMID:1900492 RGD:11035284 NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
JBrowse link
G EPO erythropoietin ISO CTD Direct Evidence: therapeutic CTD PMID:9743294 NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
JBrowse link
G IFNG interferon gamma treatment ISO RGD PMID:2119881 RGD:10755752 NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
JBrowse link
G KRAS KRAS proto-oncogene, GTPase ISO A to T transversion; Gln to His substitution RGD PMID:11295286 RGD:1598680 NCBI chr27:22,261,753...22,296,704
Ensembl chr27:22,257,941...22,293,369
JBrowse link
G NRAS NRAS proto-oncogene, GTPase ISO DNA:transversion:exon p.Q61L (human) RGD PMID:11295286 RGD:1598680 NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
JBrowse link
G SLC6A14 solute carrier family 6 member 14 ISO mRNA, protein:increased expression:brush border epithelial cell RGD PMID:17006743 RGD:1625275 NCBI chr  X:88,939,176...88,965,093
Ensembl chr  X:88,938,727...88,965,101
JBrowse link
Mammary Neoplasms, Experimental term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 ISO RGD PMID:19654309 RGD:2315553 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 ISO CTD Direct Evidence: therapeutic CTD PMID:22767648 NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr16:45,735,675...45,806,235
Ensembl chr16:45,735,703...45,804,970
JBrowse link
G ACTB actin beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:12,421,006...12,424,449
Ensembl chr 6:12,418,932...12,462,845
JBrowse link
G ACTG1 actin gamma 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:635,978...638,328
Ensembl chr 9:635,978...638,328
JBrowse link
G ACTN4 actinin alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:114,354,993...114,427,997
Ensembl chr 1:114,309,693...114,427,991
JBrowse link
G ADCY5 adenylate cyclase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr33:26,345,617...26,490,120
Ensembl chr33:26,345,617...26,504,616
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing disease_progression
treatment
ISO RGD PMID:19447866 PMID:22246620 RGD:8694414 RGD:8694468 NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
JBrowse link
G AFP alpha fetoprotein ISO CTD Direct Evidence: therapeutic CTD PMID:16322315 NCBI chr13:62,182,876...62,203,414
Ensembl chr13:62,053,814...62,294,709
JBrowse link
G AGT angiotensinogen treatment ISO RGD PMID:20837666 RGD:5129167 NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
JBrowse link
G AGTR1 angiotensin II receptor type 1 ISO RGD PMID:18421211 RGD:2292665 NCBI chr23:43,569,658...43,617,113
Ensembl chr23:43,614,035...43,616,238
JBrowse link
G AGTR2 angiotensin II receptor type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:8389152 NCBI chr  X:88,703,551...88,708,451
Ensembl chr  X:88,705,765...88,706,853
JBrowse link
G AKT1 AKT serine/threonine kinase 1 ISO RGD PMID:17210696 RGD:2315600 NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
JBrowse link
G AKT2 AKT serine/threonine kinase 2 ISO RGD PMID:17210696 RGD:2315600 NCBI chr 1:113,359,038...113,407,119
Ensembl chr 1:113,359,575...113,407,131
JBrowse link
G ALCAM activated leukocyte cell adhesion molecule ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 RGD:2306898 NCBI chr33:10,983,363...11,195,170
Ensembl chr33:10,983,363...11,370,085
JBrowse link
G ALOX5AP arachidonate 5-lipoxygenase activating protein ISO mRNA:increased expression:mammary gland tumor (rat) RGD PMID:18959458 RGD:2313895 NCBI chr25:9,320,868...9,351,056
Ensembl chr25:9,320,864...9,351,836
JBrowse link
G ANTXR1 ANTXR cell adhesion molecule 1 disease_progression ISO RGD PMID:22085271 RGD:9684855 NCBI chr10:67,829,573...68,021,368
Ensembl chr10:67,829,225...68,019,127
JBrowse link
G ANXA1 annexin A1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12376462 PMID:16316942 RGD:2306898 NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011
JBrowse link
G ANXA4 annexin A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:68,418,678...68,466,181
Ensembl chr10:68,431,056...68,466,174
JBrowse link
G APAF1 apoptotic peptidase activating factor 1 ISO RGD PMID:14973070 RGD:2325748 NCBI chr15:38,026,893...38,160,842
Ensembl chr15:38,028,132...38,114,987
JBrowse link
G APOE apolipoprotein E ISO RGD PMID:22469977 RGD:7771597 NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
JBrowse link
G AQP1 aquaporin 1 (Colton blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr14:43,592,266...43,603,903
Ensembl chr14:43,578,721...43,605,720
JBrowse link
G AR androgen receptor ISO RGD PMID:12150826 RGD:6482679 NCBI chr24:34,713,390...34,731,461
NCBI chr  X:51,969,785...52,167,450
Ensembl chr  X:51,969,785...52,151,912
JBrowse link
G AREG amphiregulin ISO protein:increased expression:mammary gland
mRNA:increased expression:mammary gland
RGD PMID:10225449 PMID:18421211 RGD:2292663 RGD:2292665 NCBI chr13:62,925,761...62,936,753
Ensembl chr13:62,926,301...62,936,738
JBrowse link
G ARHGAP5 Rho GTPase activating protein 5 disease_progression ISO mRNA:increased expression:mammary gland RGD PMID:10939588 PMID:19703301 RGD:126848766 RGD:2316183 NCBI chr 8:11,190,663...11,269,353
Ensembl chr 8:11,204,696...11,267,086
JBrowse link
G ATP5IF1 ATP synthase inhibitory factor subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 2:72,188,562...72,191,344
Ensembl chr 2:72,188,266...72,191,326
JBrowse link
G AURKA aurora kinase A ISO CTD Direct Evidence: marker/mechanism CTD PMID:12124350 NCBI chr24:41,585,483...41,604,875
Ensembl chr24:41,585,518...41,604,791
JBrowse link
G B9D2 B9 domain containing 2 ISO RGD PMID:8466857 RGD:7394797 NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
JBrowse link
G BAD BCL2 associated agonist of cell death severity
treatment
ISO RGD PMID:20732338 PMID:23404339 RGD:10053670 RGD:10053708 NCBI chr18:52,781,335...52,791,789
Ensembl chr18:52,781,921...52,791,405
JBrowse link
G BAK1 BCL2 antagonist/killer 1 ISO RGD PMID:19222350 RGD:2315700 NCBI chr12:2,950,359...2,957,604
Ensembl chr12:2,948,364...2,957,018
JBrowse link
G BASP1 brain abundant membrane attached signal protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 4:86,360,641...86,417,408
Ensembl chr 4:86,361,608...86,382,715
JBrowse link
G BAX BCL2 associated X, apoptosis regulator treatment
severity
ISO RGD PMID:20732338 PMID:23404339 RGD:10053670 RGD:10053708 NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
JBrowse link
G BCL2 BCL2 apoptosis regulator treatment ISO RGD PMID:22668016 PMID:23404339 RGD:10053670 RGD:10054128 NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
JBrowse link
G BCL2L1 BCL2 like 1 treatment ISO RGD PMID:23404339 RGD:10053670 NCBI chr24:21,145,214...21,209,425
Ensembl chr24:21,145,215...21,196,355
JBrowse link
G BRCA1 BRCA1 DNA repair associated susceptibility ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:12203372 PMID:17505536 PMID:18443292 PMID:22767648 RGD:1599502 RGD:2293149 RGD:2293155 NCBI chr 9:19,958,941...20,025,494
Ensembl chr 9:19,958,391...20,025,494
JBrowse link
G BST2 bone marrow stromal cell antigen 2 disease_progression ISO RGD PMID:23806386 RGD:14398495 NCBI chr20:45,383,757...45,387,420
Ensembl chr20:45,383,915...45,387,178
JBrowse link
G CA9 carbonic anhydrase 9 ISO RGD PMID:17280655 RGD:2293194 NCBI chr11:52,205,619...52,211,281
Ensembl chr11:52,205,668...52,211,267
JBrowse link
G CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase disease_progression ISO protein:increased expression:mammary gland RGD PMID:6030068 RGD:2303540 NCBI chr17:21,198,839...21,221,897
Ensembl chr17:21,197,826...21,221,635
JBrowse link
G CAPZB capping actin protein of muscle Z-line subunit beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:79,182,668...79,311,529
Ensembl chr 2:79,181,851...79,311,518
JBrowse link
G CASK calcium/calmodulin dependent serine protein kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr  X:35,939,117...36,296,438
Ensembl chr  X:35,940,647...36,297,014
JBrowse link
G CASP3 caspase 3 treatment
severity
ISO RGD PMID:20732338 PMID:23404339 PMID:26699876 RGD:10053670 RGD:10053708 RGD:13782283 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
JBrowse link
G CASP7 caspase 7 treatment ISO RGD PMID:23404339 PMID:23979166 PMID:26699876 RGD:10053670 RGD:13209143 RGD:13782283 NCBI chr28:24,599,866...24,630,018
Ensembl chr28:24,599,493...24,628,668
JBrowse link
G CASP8 caspase 8 severity ISO RGD PMID:20732338 RGD:10053708 NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
JBrowse link
G CASP9 caspase 9 severity
treatment
ISO RGD PMID:17297389 PMID:20012353 PMID:20732338 PMID:26699876 RGD:10053708 RGD:13782283 RGD:2315928 RGD:2315933 NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
JBrowse link
G CAV1 caveolin 1 treatment
onset
ISO protein:decreased expression:mammary gland RGD PMID:9685399 PMID:15334058 PMID:15355971 RGD:2289100 RGD:2289106 RGD:8661780 NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
JBrowse link
G CCNA2 cyclin A2 ISO protein:increased expression:mammary gland RGD PMID:10713672 RGD:2293347 NCBI chr19:18,317,866...18,324,592
Ensembl chr19:18,318,004...18,323,691
JBrowse link
G CCNB1 cyclin B1 ISO RGD PMID:11146550 RGD:2315939 NCBI chr 2:54,256,957...54,264,749 JBrowse link
G CCND1 cyclin D1 ISO mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
protein:decreased expression:mammary gland
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:12376462 PMID:12602925 PMID:12649181 PMID:14522882 PMID:16316942 More... RGD:2289336 RGD:2289337 RGD:2292404 RGD:2296037 RGD:2306898 NCBI chr18:48,501,905...48,509,684
Ensembl chr18:48,501,899...48,516,005
JBrowse link
G CCND3 cyclin D3 ISO mRNA, protein:increased expression:mammary gland RGD PMID:12853979 PMID:16311245 RGD:2316015 RGD:2316020 NCBI chr12:10,593,786...10,688,304
Ensembl chr12:10,594,712...10,600,891
JBrowse link
G CCNE1 cyclin E1 ISO protein:decreased expression:mammary gland RGD PMID:12602925 PMID:12649181 RGD:2289336 RGD:2289337 NCBI chr 1:121,688,622...121,697,533
Ensembl chr 1:121,688,796...121,697,649
JBrowse link
G CCNH cyclin H ISO mRNA:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:12606953 RGD:9590264 NCBI chr 3:21,046,477...21,067,305
Ensembl chr 3:21,046,472...21,178,315
JBrowse link
G CCR3 C-C motif chemokine receptor 3 ISO RGD PMID:21621198 RGD:6893427 NCBI chr20:42,382,380...42,398,449
Ensembl chr20:42,383,135...42,384,217
JBrowse link
G CCR5 C-C motif chemokine receptor 5 ISO RGD PMID:14597737 PMID:22637726 RGD:8551810 RGD:8551813 NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
JBrowse link
G CD274 CD274 molecule treatment ISO RGD PMID:29043842 RGD:40886270 NCBI chr 1:93,461,735...93,605,772
Ensembl chr 1:93,585,518...93,603,522
JBrowse link
G CD40 CD40 molecule ISO RGD PMID:21137078 RGD:8547744 NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
JBrowse link
G CD44 CD44 molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr18:32,735,493...32,826,483
Ensembl chr18:32,737,907...32,827,107
JBrowse link
G CDC25A cell division cycle 25A ISO RGD PMID:16951165 PMID:17283130 PMID:17638870 RGD:2754551 RGD:2764000 RGD:2771824 NCBI chr20:40,823,683...40,849,113
Ensembl chr20:40,823,459...40,847,608
JBrowse link
G CDH1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:80,757,508...80,834,878
Ensembl chr 5:80,757,508...80,834,878
JBrowse link
G CDH13 cadherin 13 severity ISO RGD PMID:18316604 RGD:2293540 NCBI chr 5:68,491,156...69,586,119
Ensembl chr 5:68,492,022...69,489,255
JBrowse link
G CDK2 cyclin dependent kinase 2 ISO RGD PMID:16924466 RGD:2293558 NCBI chr10:300,863...306,546
Ensembl chr10:300,903...305,438
JBrowse link
G CDK4 cyclin dependent kinase 4 susceptibility ISO protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:12376462 PMID:14522882 PMID:16413469 PMID:25221644 RGD:2293577 RGD:2293581 NCBI chr10:1,812,864...1,815,815
Ensembl chr10:1,812,886...1,815,789
JBrowse link
G CDK6 cyclin dependent kinase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25221644 NCBI chr14:18,178,352...18,413,869
Ensembl chr14:18,188,429...18,419,869
JBrowse link
G CDKL2 cyclin dependent kinase like 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25333262 NCBI chr32:158,140...206,860
Ensembl chr32:159,332...202,617
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B treatment ISO protein:increased expression:mammary gland RGD PMID:15844214 PMID:22651929 RGD:10045559 RGD:2293626 NCBI chr27:33,609,154...33,613,558
Ensembl chr27:33,611,760...33,612,906
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A disease_progression ISO RGD PMID:18060046 PMID:20681787 RGD:2289674 RGD:8552689 NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379
JBrowse link
G CDS1 CDP-diacylglycerol synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr32:8,349,033...8,416,451
Ensembl chr32:8,349,027...8,415,295
JBrowse link
G CLU clusterin disease_progression ISO RGD PMID:23099883 RGD:8699504 NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
JBrowse link
G CNN3 calponin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:54,378,031...54,405,009
Ensembl chr 6:54,368,162...54,404,201
JBrowse link
G COL18A1 collagen type XVIII alpha 1 chain severity ISO RGD PMID:10766159 RGD:70690 NCBI chr31:38,915,872...38,957,484 JBrowse link
G COL5A1 collagen type V alpha 1 chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 9:50,706,852...50,856,691
Ensembl chr 9:50,770,277...50,854,728
JBrowse link
G CSF1 colony stimulating factor 1 ISO RGD PMID:15205327 RGD:2293710 NCBI chr 6:42,028,454...42,047,028
Ensembl chr 6:42,034,149...42,049,371
JBrowse link
G CSN2 casein beta ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:9879772 PMID:16316942 RGD:2306898 NCBI chr13:59,436,726...59,444,398
Ensembl chr13:59,438,601...59,444,398
JBrowse link
G CSN3 casein kappa ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 RGD:2306898 NCBI chr13:59,613,026...59,629,095
Ensembl chr13:59,621,106...59,626,552
JBrowse link
G CSNK2A1 casein kinase 2 alpha 1 ISO RGD PMID:11827167 RGD:727632 NCBI chr24:20,333,593...20,390,341 JBrowse link
G CTNNB1 catenin beta 1 ISO DNA:missense mutations: :p.S33Y, p.S45F
protein:increased expression:mammary gland
RGD PMID:17510243 PMID:18060046 RGD:2289674 RGD:2289816 NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927
JBrowse link
G DBI diazepam binding inhibitor, acyl-CoA binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr19:30,640,429...30,645,704
Ensembl chr19:30,640,429...30,646,405
JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:21283680 PMID:29298894 RGD:151347446 NCBI chr12:653,800...671,190
Ensembl chr12:653,807...670,543
JBrowse link
G DES desmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr37:25,933,525...25,939,910
Ensembl chr37:25,933,455...25,940,985
JBrowse link
G DIO1 iodothyronine deiodinase 1 ISO RGD PMID:11765219 RGD:727335 NCBI chr 5:55,081,894...55,098,560
Ensembl chr 5:55,082,604...55,098,529
JBrowse link
G DNMT3B DNA methyltransferase 3 beta treatment ISO RGD PMID:24447120 RGD:9588304 NCBI chr24:22,096,386...22,123,378
Ensembl chr24:22,096,349...22,122,900
JBrowse link
G DUSP1 dual specificity phosphatase 1 treatment ISO RGD PMID:20837666 RGD:5129167 NCBI chr 4:39,588,833...39,591,065
Ensembl chr 4:39,588,339...39,590,514
JBrowse link
G DUSP6 dual specificity phosphatase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:30,322,472...30,327,221
Ensembl chr15:30,323,697...30,326,508
JBrowse link
G EEF1A1 eukaryotic translation elongation factor 1 alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr12:35,576,576...35,581,339
Ensembl chr12:35,576,576...35,581,230
JBrowse link
G EFEMP1 EGF containing fibulin extracellular matrix protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr10:56,632,801...56,694,872
Ensembl chr10:56,579,899...56,787,187
JBrowse link
G EGFR epidermal growth factor receptor ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:2523869 PMID:8603490 PMID:17203220 RGD:2289979 NCBI chr18:5,983,669...6,044,092
Ensembl chr18:5,982,770...6,042,631
JBrowse link
G EIF5A eukaryotic translation initiation factor 5A ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:32,268,103...32,272,970 JBrowse link
G ENO1 enolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:62,300,805...62,314,508
Ensembl chr 5:62,300,808...62,304,093
JBrowse link
G EPCAM epithelial cell adhesion molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:49,446,165...49,498,690
Ensembl chr10:49,485,746...49,498,475
JBrowse link
G EPHX1 epoxide hydrolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 7:38,964,319...39,004,902
Ensembl chr 7:38,964,338...38,999,238
JBrowse link
G EPO erythropoietin treatment ISO RGD PMID:12118093 RGD:11041669 NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
JBrowse link
G EPOR erythropoietin receptor treatment ISO RGD PMID:12118093 RGD:11041669 NCBI chr20:49,945,777...49,950,856
Ensembl chr20:49,945,777...49,950,856
JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism
Androgen-dependent
CTD
RGD
PMID:1913683 PMID:8603490 PMID:12150826 PMID:17203220 PMID:25221644 RGD:2289920 RGD:2289979 RGD:6482679 NCBI chr 9:22,760,373...22,785,367
Ensembl chr 9:22,759,256...22,785,294
JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 ISO RGD PMID:17203220 RGD:2289979 NCBI chr10:406,856...424,746
Ensembl chr10:406,633...424,264
JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 ISO RGD PMID:17203220 RGD:2289979 NCBI chr37:19,029,647...20,134,576
Ensembl chr37:19,037,217...20,134,426
JBrowse link
G ESR1 estrogen receptor 1 susceptibility ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:epithelial cell, nucleus
RGD
CTD
PMID:11759285 PMID:15637090 PMID:18055862 RGD:2290019 RGD:8552983 RGD:8553057 NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
JBrowse link
G ESR2 estrogen receptor 2 treatment ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:epithelial cell, nucleus
RGD
CTD
PMID:15637090 PMID:24078029 RGD:7364911 RGD:8552983 NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
JBrowse link
G EZR ezrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:48,160,206...48,210,036
Ensembl chr 1:48,160,206...48,210,036
JBrowse link
G F11R F11 receptor ISO RGD PMID:22120722 RGD:7488922 NCBI chr38:21,433,819...21,456,722
Ensembl chr38:21,451,952...21,454,959
JBrowse link
G FABP4 fatty acid binding protein 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr29:28,651,550...28,656,255
Ensembl chr29:28,652,146...28,656,228
JBrowse link
G FAS Fas cell surface death receptor ISO RGD PMID:18094967 RGD:2290047 NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
JBrowse link
G FBXO10 F-box protein 10 ISO RGD PMID:17404222 RGD:1601189 NCBI chr11:53,833,335...53,885,416
Ensembl chr11:53,835,003...53,896,930
JBrowse link
G FGF10 fibroblast growth factor 10 ISO mRNA:increased expression:mammary gland RGD PMID:18421211 RGD:2292665 NCBI chr 4:65,851,130...65,930,944
Ensembl chr 4:65,851,069...65,928,192
JBrowse link
G FGF7 fibroblast growth factor 7 ISO RGD PMID:9000125 RGD:2301094 NCBI chr30:15,555,016...15,608,230
Ensembl chr30:15,555,266...15,606,521
JBrowse link
G FGF8 fibroblast growth factor 8 ISO RGD PMID:9840935 RGD:2301098 NCBI chr28:14,362,407...14,367,109
Ensembl chr28:14,362,109...14,367,468
JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 ISO RGD PMID:10498246 RGD:2302211 NCBI chr25:11,551,372...11,670,891
Ensembl chr25:11,581,206...11,692,284
JBrowse link
G FN1 fibronectin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr37:22,456,854...22,522,410
Ensembl chr37:22,420,428...22,523,123
JBrowse link
G FRMPD1 FERM and PDZ domain containing 1 ISO RGD PMID:17404222 RGD:1601189 NCBI chr11:53,901,625...54,051,885
Ensembl chr11:53,939,807...54,051,756
JBrowse link
G FURIN furin, paired basic amino acid cleaving enzyme ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 3:53,357,491...53,368,285
Ensembl chr 3:53,358,045...53,365,423
JBrowse link
G G0S2 G0/G1 switch 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:8,335,699...8,336,615
Ensembl chr 7:8,336,015...8,336,302
JBrowse link
G GATA3 GATA binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:28,068,143...28,098,445
Ensembl chr 2:28,069,051...28,087,760
JBrowse link
G GATM glycine amidinotransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr30:11,724,446...11,742,214
Ensembl chr30:11,723,519...11,742,214
JBrowse link
G GDA guanine deaminase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:85,506,598...85,586,212
Ensembl chr 1:85,444,917...85,586,163
JBrowse link
G GGT1 gamma-glutamyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr26:28,301,455...28,315,029 JBrowse link
G GNAI2 G protein subunit alpha i2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr20:39,075,085...39,094,697
Ensembl chr20:39,075,085...39,094,697
JBrowse link
G GSK3B glycogen synthase kinase 3 beta treatment ISO RGD PMID:28810530 RGD:13792729 NCBI chr33:23,458,369...23,659,878
Ensembl chr33:23,463,767...23,659,666
JBrowse link
G GSN gelsolin ISO mRNA:decreased expression RGD PMID:8895730 RGD:1599869 NCBI chr11:74,248,227...74,268,129
Ensembl chr11:74,233,457...74,268,129
JBrowse link
G GSS glutathione synthetase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr24:23,973,807...24,000,281
Ensembl chr24:23,901,045...23,997,286
JBrowse link
G H2AX H2A.X variant histone treatment ISO RGD PMID:22384017 RGD:7240549 NCBI chr 5:14,765,625...14,766,590
Ensembl chr 5:14,766,126...14,766,557
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha treatment ISO RGD PMID:17280655 RGD:2293194 NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
JBrowse link
G HMOX1 heme oxygenase 1 treatment ISO CTD Direct Evidence: therapeutic RGD
CTD
PMID:16319139 PMID:23215791 RGD:10755708 NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
JBrowse link
G HNRNPA1 heterogeneous nuclear ribonucleoprotein A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr27:1,013,459...1,020,083
Ensembl chr27:1,015,868...1,019,891
JBrowse link
G HNRNPAB heterogeneous nuclear ribonucleoprotein A/B ISO CTD Direct Evidence: marker/mechanism CTD PMID:15538050 NCBI chr11:3,355,051...3,360,376
Ensembl chr11:3,355,050...3,360,258
JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO DNA:mutation: :p.G12E (rat)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:8185828 PMID:11376698 PMID:19652463 RGD:2314834 NCBI chr18:25,642,844...25,644,717
Ensembl chr18:25,642,844...25,644,717
JBrowse link
G ID1 inhibitor of DNA binding 1, HLH protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr24:21,094,339...21,096,276
Ensembl chr24:21,094,755...21,096,276
JBrowse link
G ID3 inhibitor of DNA binding 3, HLH protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:75,880,659...75,881,786
Ensembl chr 2:75,880,657...75,882,010
JBrowse link
G ID4 inhibitor of DNA binding 4, HLH protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:14633621 NCBI chr35:18,358,518...18,360,767
Ensembl chr35:18,357,826...18,359,011
Ensembl chr35:18,357,826...18,359,011
JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:15217511 PMID:15528971 PMID:17584969 PMID:23342276 RGD:8549490 NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
JBrowse link
G IL10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14999141 NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
JBrowse link
G IL18BP interleukin 18 binding protein ISO mRNA:increased expression:mammary gland RGD PMID:18959458 RGD:2313895 NCBI chr21:26,076,515...26,080,741
Ensembl chr21:26,076,700...26,078,612
JBrowse link
G IL1RN interleukin 1 receptor antagonist treatment ISO human protein in a mouse model RGD PMID:21890879 RGD:6771361 NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
JBrowse link
G IL6ST interleukin 6 cytokine family signal transducer ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 2:43,214,050...43,273,014
Ensembl chr 2:43,214,050...43,248,124
JBrowse link
G ILK integrin linked kinase ISO late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands RGD PMID:11704830 RGD:2301733 NCBI chr21:29,911,326...29,917,972
Ensembl chr21:29,911,364...29,917,974
JBrowse link
G INSIG1 insulin induced gene 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr16:18,260,456...18,271,855
Ensembl chr16:18,259,935...18,271,378
JBrowse link
G ITGB3 integrin subunit beta 3 ISO protein:increased expression:mammary gland: RGD PMID:22022542 RGD:8693386 NCBI chr 9:9,179,667...9,231,061
Ensembl chr 9:9,182,562...9,231,451
JBrowse link
G KDR kinase insert domain receptor ISO inhibition prevents DMBA-induced atypical ductal hyperplasia and carcinoma in situ RGD PMID:15170218 PMID:19888452 RGD:2291936 RGD:5684399 NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
JBrowse link
G KIT KIT proto-oncogene, receptor tyrosine kinase ISO DNA:mutation (rat) RGD PMID:18445266 RGD:2302172 NCBI chr13:47,108,442...47,190,935
Ensembl chr13:47,108,504...47,190,029
JBrowse link
G KITLG KIT ligand ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:29,591,068...29,671,985
Ensembl chr15:29,591,170...29,671,974
JBrowse link
G KRT7 keratin 7 ISO RGD PMID:8570173 RGD:2317439 NCBI chr27:2,812,709...2,827,451 JBrowse link
G KRT71 keratin 71 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr27:2,536,831...2,545,103 JBrowse link
G KRT81 keratin 81 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr27:2,776,693...2,782,016 JBrowse link
G LEP leptin treatment ISO RGD PMID:22246620 RGD:8694468 NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
JBrowse link
G LHCGR luteinizing hormone/choriogonadotropin receptor ISO mRNA:splice variant (rat) RGD PMID:15044717 RGD:2302177 NCBI chr10:50,540,706...50,594,336
Ensembl chr10:50,541,960...50,598,036
JBrowse link
G LIN7A lin-7 homolog A, crumbs cell polarity complex component ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr15:23,101,524...23,186,343
Ensembl chr15:23,111,944...23,187,354
JBrowse link
G LNPEP leucyl and cystinyl aminopeptidase ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:serum
CTD
RGD
PMID:16619500 RGD:1582109 NCBI chr 3:12,668,994...12,766,712
Ensembl chr 3:12,681,577...12,767,183
JBrowse link
G LOC100855540 hemoglobin subunit alpha-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:40,324,378...40,325,427 JBrowse link
G LOC100856382 matrix Gla protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr27:31,735,301...31,738,673
Ensembl chr27:31,734,660...31,738,673
JBrowse link
G LOC102156002 BRCA1-associated RING domain protein 1-like ISO RGD PMID:18443292 RGD:2293149 NCBI chr 8:2,420,559...2,423,280 JBrowse link
G LOC403934 cell division cycle 42 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:77,153,276...77,169,947
Ensembl chr 2:77,153,095...77,199,211
JBrowse link
G LOC477072 serotransferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:9879772 PMID:16316942 NCBI chr23:30,658,250...30,683,816
Ensembl chr23:30,595,704...30,683,845
JBrowse link
G LOC478702 tubulin beta-2B chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr35:3,494,982...3,498,274
Ensembl chr35:3,495,277...3,498,248
JBrowse link
G LPL lipoprotein lipase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr25:37,078,306...37,102,729
Ensembl chr25:37,079,756...37,102,700
JBrowse link
G LSR lipolysis stimulated lipoprotein receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 1:117,319,672...117,333,426
Ensembl chr 1:117,319,658...117,333,419
JBrowse link
G MAP2K3 mitogen-activated protein kinase kinase 3 ISO RGD PMID:24233520 RGD:7495808 NCBI chr 5:42,732,751...42,762,420
Ensembl chr 5:42,700,836...42,761,736
JBrowse link
G MAP2K7 mitogen-activated protein kinase kinase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21317887 NCBI chr20:52,594,450...52,604,236
Ensembl chr20:52,594,536...52,602,150
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 treatment ISO RGD PMID:29435821 RGD:13800872 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 treatment ISO RGD PMID:29435821 RGD:13800872 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
G MDH2 malate dehydrogenase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:7,389,266...7,405,311 JBrowse link
G MIF macrophage migration inhibitory factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462
G MIR155 microRNA mir-155 ISO RGD PMID:20354188 PMID:29643534 RGD:21079418 RGD:21403681 NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
JBrowse link
G MMP1 matrix metallopeptidase 1 treatment ISO RGD PMID:19622769 RGD:8549722 NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
JBrowse link
G MMP13 matrix metallopeptidase 13 severity ISO RGD PMID:18698413 RGD:2306081 NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121
JBrowse link
G MMP15 matrix metallopeptidase 15 ISO mRNA:increased expression:mammary gland RGD PMID:15895410 RGD:2314949 NCBI chr 2:58,501,783...58,512,507
Ensembl chr 2:58,504,848...58,512,371
JBrowse link
G MMP2 matrix metallopeptidase 2 treatment ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:mammary gland
RGD
CTD
PMID:19725228 PMID:23359979 PMID:28574600 RGD:2325823 RGD:8657038 NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
JBrowse link
G MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) ISO RGD PMID:10428026 RGD:8662909 NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
JBrowse link
G MMP7 matrix metallopeptidase 7 onset ISO RGD PMID:9850086 RGD:9685350 NCBI chr 5:29,187,902...29,196,157
Ensembl chr 5:29,187,851...29,196,153
JBrowse link
G MMP9 matrix metallopeptidase 9 treatment ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland
CTD
RGD
PMID:19725228 PMID:21283680 PMID:23359979 RGD:2325823 RGD:8657038 NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
JBrowse link
G MPZL1 myelin protein zero like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:30,670,506...30,741,464
Ensembl chr 7:30,672,840...30,741,484
JBrowse link
G MRC2 mannose receptor C type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:10,816,079...10,872,467
Ensembl chr 9:10,816,094...10,871,369
JBrowse link
G MT-CO1 mitochondrially encoded cytochrome c oxidase I ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr MT:5,349...6,893
Ensembl chr MT:5,349...6,893
JBrowse link
G MTOR mechanistic target of rapamycin kinase ISO RGD PMID:22349822 RGD:10040957 NCBI chr 2:84,818,893...84,939,283
Ensembl chr 2:84,787,708...84,939,114
JBrowse link
G MUC1 mucin 1, cell surface associated treatment ISO RGD PMID:23015160 RGD:7349374 NCBI chr 7:42,338,939...42,344,690
Ensembl chr 7:42,340,375...42,344,690
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor treatment ISO RGD PMID:22384017 RGD:7240549 NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
JBrowse link
G NCOA1 nuclear receptor coactivator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21080969 NCBI chr17:18,880,676...19,124,300
Ensembl chr17:18,880,383...19,122,258
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 treatment ISO RGD PMID:22072621 RGD:10412719 NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
JBrowse link
G NOTCH4 notch receptor 4 ISO RGD PMID:15531924 RGD:2299154 NCBI chr12:1,585,249...1,608,721
Ensembl chr12:1,587,918...1,607,760
JBrowse link
G NSMF NMDA receptor synaptonuclear signaling and neuronal migration factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 9:48,287,019...48,295,540
Ensembl chr 9:48,287,014...48,294,780
JBrowse link
G NUDT1 nudix hydrolase 1 ISO mRNA:increased expression:mammary gland RGD PMID:12036445 RGD:724605 NCBI chr 6:14,874,459...14,881,517
Ensembl chr 6:14,859,518...14,882,704
JBrowse link
G OXT oxytocin/neurophysin I prepropeptide ISO CTD Direct Evidence: therapeutic CTD PMID:8647655 PMID:15089975 NCBI chr24:18,193,381...18,194,232
Ensembl chr24:18,193,339...18,194,170
JBrowse link
G PADI4 peptidyl arginine deiminase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:80,912,814...80,942,767
Ensembl chr 2:80,905,391...80,993,973
JBrowse link
G PAK4 p21 (RAC1) activated kinase 4 ISO RGD PMID:20697354 RGD:7775027 NCBI chr 1:114,009,573...114,052,100
Ensembl chr 1:114,009,711...114,018,191
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 treatment ISO RGD PMID:23404339 RGD:10053670 NCBI chr 7:38,503,072...38,542,556
Ensembl chr 7:38,503,067...38,542,127
JBrowse link
G PCNA proliferating cell nuclear antigen ISO mRNA,protein:increased expression:mammary gland: RGD PMID:2567593 RGD:10448972 NCBI chr24:16,478,774...16,485,992
Ensembl chr24:16,478,769...16,484,992
JBrowse link
G PCP4 Purkinje cell protein 4 ISO mRNA,protein:increased expression:cytoplasm: RGD PMID:19480007 RGD:9850273 NCBI chr31:34,529,688...34,584,497
Ensembl chr31:34,529,683...34,584,501
JBrowse link
G PDGFA platelet derived growth factor subunit A ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:16316942 RGD:2292404 RGD:2306898 NCBI chr 6:16,271,082...16,293,246
Ensembl chr 6:16,270,104...16,292,396
JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr26:14,522,124...14,526,370
Ensembl chr26:14,500,074...14,529,354
JBrowse link
G PGAM1 phosphoglycerate mutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr28:10,720,235...10,727,709
Ensembl chr28:10,720,094...10,930,286
JBrowse link
G PGR progesterone receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15637090 NCBI chr21:447,197...552,511
Ensembl chr21:447,319...552,511
JBrowse link
G PHB1 prohibitin 1 ISO mRNA, protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:12376462 RGD:2292404 NCBI chr 9:25,525,711...25,536,722
Ensembl chr 9:25,526,649...25,536,722
JBrowse link
G PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 2:53,447,802...53,527,563
Ensembl chr 2:53,448,286...53,524,970
JBrowse link
G PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 ISO RGD PMID:22064478 RGD:8693420 NCBI chr20:51,156,887...51,168,131
Ensembl chr20:51,157,121...51,168,136
JBrowse link
G PKM pyruvate kinase M1/2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr30:35,712,853...35,737,643 JBrowse link
G PLAU plasminogen activator, urokinase disease_progression ISO RGD PMID:18052026 RGD:6484140 NCBI chr 4:24,329,139...24,333,893
Ensembl chr 4:24,328,925...24,334,851
JBrowse link
G PLK2 polo like kinase 2 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 RGD:2292404 NCBI chr 2:45,359,865...45,365,496
Ensembl chr 2:45,360,374...45,367,441
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:11137312 NCBI chr10:19,934,020...20,006,096
Ensembl chr10:19,934,165...20,006,146
JBrowse link
G PRDX2 peroxiredoxin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr20:49,352,271...49,356,755
Ensembl chr20:49,352,266...49,356,682
JBrowse link
G PRL prolactin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr35:20,673,830...20,683,824
Ensembl chr35:20,673,839...20,683,824
JBrowse link
G PRLR prolactin receptor ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 RGD:2306898 NCBI chr 4:73,147,919...73,280,970
Ensembl chr 4:73,110,858...73,273,916
JBrowse link
G PSMA4 proteasome 20S subunit alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942
G PSME1 proteasome activator subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 8:4,131,197...4,134,001
Ensembl chr 8:4,131,345...4,134,006
JBrowse link
G PTBP1 polypyrimidine tract binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr20:57,806,450...57,818,435
Ensembl chr20:57,807,826...57,818,359
JBrowse link
G PTEN phosphatase and tensin homolog onset ISO RGD PMID:18381417 RGD:2292496 NCBI chr26:37,853,148...37,913,176
Ensembl chr26:37,835,661...37,913,176
JBrowse link
G PTGER1 prostaglandin E receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11751431 NCBI chr20:48,156,055...48,159,838
Ensembl chr20:48,157,973...48,159,921
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO mRNA:increased expression:breast RGD PMID:18279516 PMID:18676768 PMID:21623034 RGD:2300118 RGD:2300130 RGD:5135030 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
G PTK2 protein tyrosine kinase 2 disease_progression ISO CTD Direct Evidence: therapeutic CTD
RGD
PMID:15930288 PMID:18056629 PMID:24809783 RGD:2292554 RGD:2292560 NCBI chr13:35,302,439...35,541,336
Ensembl chr13:35,303,380...35,541,294
JBrowse link
G PTN pleiotrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr16:11,283,078...11,382,820
Ensembl chr16:11,283,077...11,382,814
JBrowse link
G PTPRB protein tyrosine phosphatase receptor type B treatment ISO RGD PMID:23899555 RGD:151660352 NCBI chr10:12,267,891...12,384,522
Ensembl chr10:12,241,716...12,384,435
JBrowse link
G RAN RAN, member RAS oncogene family ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr26:1,435,077...1,436,893
Ensembl chr26:1,434,720...1,436,993
JBrowse link
G RASA1 RAS p21 protein activator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 3:21,068,182...21,177,288
Ensembl chr 3:21,054,930...21,176,757
JBrowse link
G RASGRF2 Ras protein specific guanine nucleotide releasing factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 3:26,047,304...26,286,919
Ensembl chr 3:26,050,260...26,286,819
JBrowse link
G RB1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14522882 NCBI chr22:3,061,621...3,204,625
Ensembl chr22:3,063,239...3,257,726
JBrowse link
G RBP1 retinol binding protein 1 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 RGD:2292404 NCBI chr23:35,677,844...35,698,194
Ensembl chr23:35,679,176...35,698,363
JBrowse link
G RBP4 retinol binding protein 4 ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 RGD:2306898 NCBI chr28:7,822,936...7,830,735
Ensembl chr28:7,822,944...7,830,750
JBrowse link
G RCN1 reticulocalbin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr18:35,373,175...35,393,389
Ensembl chr18:35,374,116...35,395,528
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO protein:decreased expression:peritoneal macrophage RGD PMID:16288051 RGD:2298764 NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit ISO RGD PMID:16260626 RGD:7777148 NCBI chr 1:110,436,677...110,466,709
Ensembl chr 1:110,436,662...110,466,809
JBrowse link
G RNPEP arginyl aminopeptidase ISO protein:increased expression:serum
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:16619500 RGD:1582109 NCBI chr 7:966,563...985,169
Ensembl chr 7:966,607...984,714
JBrowse link
G RPL3 ribosomal protein L3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:25,739,089...25,745,487
Ensembl chr10:25,739,089...25,762,501
JBrowse link
G RPL6 ribosomal protein L6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr26:9,970,416...9,975,897 JBrowse link
G RPS14 ribosomal protein S14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:58,661,335...58,667,968
Ensembl chr 4:58,661,152...58,667,964
JBrowse link
G RUNX1 RUNX family transcription factor 1 ISO mRNA:increased expression:mammary gland RGD PMID:29435983 RGD:126779584 NCBI chr31:30,170,859...30,420,344
Ensembl chr31:30,170,605...30,420,839
JBrowse link
G RXRA retinoid X receptor alpha ISO RGD PMID:16344269 RGD:1643109 NCBI chr 9:50,525,195...50,575,720
Ensembl chr 9:50,484,567...50,573,119
JBrowse link
G S100A6 S100 calcium binding protein A6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:43,501,430...43,503,100
Ensembl chr 7:43,501,989...43,541,604
JBrowse link
G S1PR1 sphingosine-1-phosphate receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:48,897,320...48,902,206
Ensembl chr 6:48,897,449...48,900,037
JBrowse link
G SCARB1 scavenger receptor class B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr26:5,035,797...5,122,383
Ensembl chr26:5,049,407...5,121,468
JBrowse link
G SCD stearoyl-CoA desaturase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr28:13,112,741...13,129,129
Ensembl chr28:13,113,006...13,125,801
JBrowse link
G SELENOP selenoprotein P ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 4:66,953,060...66,964,162
Ensembl chr 4:66,956,405...66,959,043
JBrowse link
G SGK1 serum/glucocorticoid regulated kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:27,086,431...27,196,601
Ensembl chr 1:27,087,361...27,196,521
JBrowse link
G SLC12A2 solute carrier family 12 member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr11:17,143,943...17,256,248
Ensembl chr11:17,143,943...17,253,695
JBrowse link
G SLC25A10 solute carrier family 25 member 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 9:483,864...491,613 JBrowse link
G SNCG synuclein gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:34,604,867...34,608,851
Ensembl chr 4:34,605,091...34,608,842
JBrowse link
G SNRPD3 small nuclear ribonucleoprotein D3 polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr26:28,247,878...28,263,519 JBrowse link
G SOCS1 suppressor of cytokine signaling 1 ISO mRNA:increased expression:mammary gland RGD PMID:18381452 PMID:20354188 RGD:21079418 RGD:2298899 NCBI chr 6:31,511,003...31,511,995
Ensembl chr 6:31,509,268...31,511,557
JBrowse link
G SOCS3 suppressor of cytokine signaling 3 ISO mRNA:increased expression:mammary gland RGD PMID:18381452 RGD:2298899 NCBI chr 9:2,859,267...2,859,944 JBrowse link
G SOD2 superoxide dismutase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23964924 NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
JBrowse link
G SOX9 SRY-box transcription factor 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:8,275,049...8,278,172
Ensembl chr 9:8,275,049...8,278,172
JBrowse link
G SPINT2 serine peptidase inhibitor, Kunitz type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:114,699,050...114,727,802
Ensembl chr 1:114,699,241...114,727,763
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:15318939 NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
JBrowse link
G SRSF2 serine and arginine rich splicing factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:4,028,414...4,032,371
Ensembl chr 9:4,028,482...4,030,793
JBrowse link
G STAT1 signal transducer and activator of transcription 1 ISO RGD PMID:11325527 RGD:2291895 NCBI chr37:1,513,438...1,549,837
Ensembl chr37:1,507,219...1,550,178
JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
RGD
CTD
PMID:16316942 PMID:17483332 RGD:2291914 RGD:2306898 NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
JBrowse link
G STAT5A signal transducer and activator of transcription 5A susceptibility ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
protein:altered localization:nucleus
protein:increased tyrosine phosphorylation:mammary gland
CTD
RGD
PMID:12082622 PMID:12376462 PMID:15609129 PMID:16316942 PMID:17173897 More... RGD:151665819 RGD:2291927 RGD:2291932 RGD:2292404 RGD:2298539 RGD:2306898 NCBI chr 9:20,616,041...20,638,523
Ensembl chr 9:20,617,151...20,638,103
JBrowse link
G STAT6 signal transducer and activator of transcription 6 ISO DNA:gene knockout::Balb/C-derived Stat6(-/-) mice resistant to growth of implanted Balb/C mammary tumors RGD PMID:11086031 RGD:2298563 NCBI chr10:1,232,515...1,247,011
Ensembl chr10:1,233,691...1,247,075
JBrowse link
G STC2 stanniocalcin 2 ISO mRNA:increased expression:mammary gland RGD PMID:18959458 RGD:2313895 NCBI chr 4:39,151,951...39,165,514
Ensembl chr 4:39,152,503...39,162,343
JBrowse link
G STMN1 stathmin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:74,035,462...74,043,352
Ensembl chr 2:74,035,457...74,043,349
JBrowse link
G TDG thymine DNA glycosylase ISO mRNA:increased expression:mammary gland tumor (mouse) RGD PMID:9794235 RGD:2317355 NCBI chr15:42,493,593...42,516,868
Ensembl chr15:42,493,737...42,515,448
JBrowse link
G TFF1 trefoil factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr31:36,681,478...36,684,571
Ensembl chr31:36,681,357...36,695,665
JBrowse link
G TGFA transforming growth factor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:8603490 NCBI chr10:68,915,671...68,957,027 JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 ISO RGD PMID:12808151 RGD:737735 NCBI chr11:56,191,383...56,223,042
Ensembl chr11:56,161,772...56,218,594
JBrowse link
G TGFBR2 transforming growth factor beta receptor 2 ISO RGD PMID:12808151 RGD:737735 NCBI chr23:13,886,869...13,946,480
Ensembl chr23:13,889,000...13,977,636
JBrowse link
G THBS1 thrombospondin 1 ISO mRNA:increased expression:mammary gland RGD PMID:15459484 RGD:1626167 NCBI chr30:6,770,212...6,786,875
Ensembl chr30:6,769,470...6,784,915
JBrowse link
G THRSP thyroid hormone responsive ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr21:20,759,291...20,761,740
Ensembl chr21:20,761,109...20,761,558
JBrowse link
G TKT transketolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr20:36,690,540...36,705,980
Ensembl chr20:36,681,531...36,742,199
JBrowse link
G TLE4 TLE family member 4, transcriptional corepressor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:79,126,261...79,268,052
Ensembl chr 1:79,127,501...79,268,148
JBrowse link
G TNF tumor necrosis factor ISO RGD PMID:19755514 RGD:7401185 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
JBrowse link
G TNFSF10 TNF superfamily member 10 ISO CTD Direct Evidence: therapeutic CTD PMID:21252285 NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060
JBrowse link
G TP53 tumor protein p53 disease_progression ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:17470299 PMID:18092324 PMID:24809783 RGD:2290539 RGD:2290577 NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
JBrowse link
G TPM3 tropomyosin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 7:43,039,360...43,067,297
Ensembl chr 7:43,039,382...43,067,296
JBrowse link
G TRPS1 transcriptional repressor GATA binding 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr13:15,017,180...15,273,177
Ensembl chr13:15,022,652...15,273,666
JBrowse link
G TSC22D1 TSC22 domain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr22:6,375,585...6,506,511
Ensembl chr22:6,375,577...6,505,672
JBrowse link
G TXNIP thioredoxin interacting protein severity ISO mRNA:decreased expression:mammary gland RGD PMID:15170812 RGD:1642758 NCBI chr17:58,775,588...58,779,730
Ensembl chr17:58,776,871...58,779,531
JBrowse link
G TYMS thymidylate synthetase ISO RGD PMID:9635926 RGD:2315839 NCBI chr 7:67,487,927...67,497,747
Ensembl chr 7:67,487,927...67,497,747
JBrowse link
G UBE2I ubiquitin conjugating enzyme E2 I ISO CTD Direct Evidence: marker/mechanism
MCF-7 human breast cancer cell tumors grown in nude mice
CTD
RGD
PMID:15735760 PMID:16316942 RGD:2301345 NCBI chr 6:39,440,123...39,453,688
Ensembl chr 6:39,440,314...39,817,588
JBrowse link
G UCP2 uncoupling protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr21:24,304,410...24,311,392
Ensembl chr21:24,304,457...24,311,128
JBrowse link
G VAMP8 vesicle associated membrane protein 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr17:39,497,628...39,501,734
Ensembl chr17:39,497,785...39,501,739
JBrowse link
G VDR vitamin D receptor ISO RGD PMID:15333467 RGD:8158073 NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
JBrowse link
G VEGFA vascular endothelial growth factor A treatment ISO human protein in a mouse model RGD PMID:21890879 RGD:6771361 NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
JBrowse link
G WNT1 Wnt family member 1 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr27:5,588,151...5,592,254
Ensembl chr27:5,574,940...5,592,060
JBrowse link
G WNT2 Wnt family member 2 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr14:56,123,735...56,172,113
Ensembl chr14:56,129,248...56,172,069
JBrowse link
G WNT3 Wnt family member 3 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 RGD:2298848 NCBI chr 9:10,073,019...10,124,454
Ensembl chr 9:10,077,567...10,124,508
JBrowse link
G WNT3A Wnt family member 3A ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr14:864,393...899,698
Ensembl chr14:863,424...896,412
JBrowse link
G WNT5B Wnt family member 5B no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr27:43,662,482...43,679,713
Ensembl chr27:43,620,284...43,677,078
JBrowse link
G WNT6 Wnt family member 6 no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr37:25,452,875...25,457,437
Ensembl chr37:25,453,905...25,456,654
JBrowse link
G WNT7A Wnt family member 7A ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr20:4,072,010...4,139,521
Ensembl chr20:4,073,929...4,139,436
JBrowse link
G WNT7B Wnt family member 7B no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr10:20,160,916...20,208,786
Ensembl chr10:20,160,206...20,243,160
JBrowse link
G XDH xanthine dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr17:24,900,708...24,960,748
Ensembl chr17:24,901,447...24,971,935
JBrowse link
G XIAP X-linked inhibitor of apoptosis ISO CTD Direct Evidence: therapeutic CTD PMID:12766084 NCBI chr  X:95,300,234...95,356,103
Ensembl chr  X:95,331,827...95,351,582
JBrowse link
G XRCC3 X-ray repair cross complementing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr 8:71,441,732...71,452,922
Ensembl chr 8:71,442,429...71,449,408
JBrowse link
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr13:2,729,404...2,764,422 JBrowse link
Sarcoma, Yoshida term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DPYD dihydropyrimidine dehydrogenase treatment ISO RGD PMID:8138551 RGD:11251753 NCBI chr 6:51,789,786...52,564,802
Ensembl chr 6:51,814,573...52,580,923
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 14720
    disease of cellular proliferation 6893
      Experimental Neoplasms 473
        Carcinoma 256, Walker 0
        Carcinoma, Brown-Pearce 0
        Carcinoma, Krebs 2 0
        Carcinoma, Lewis Lung 11
        Ehrlich tumor carcinoma 3
        Experimental Leukemia + 9
        Experimental Liver Neoplasms 146
        Experimental Melanoma 23
        Experimental Sarcoma + 9
        Mammary Neoplasms, Experimental 278
Path 2
Term Annotations click to browse term
  disease 14720
    Animal Diseases 1296
      Animal Disease Models 1251
        Experimental Neoplasms 473
          Carcinoma 256, Walker 0
          Carcinoma, Brown-Pearce 0
          Carcinoma, Krebs 2 0
          Carcinoma, Lewis Lung 11
          Ehrlich tumor carcinoma 3
          Experimental Leukemia + 9
          Experimental Liver Neoplasms 146
          Experimental Melanoma 23
          Experimental Sarcoma + 9
          Mammary Neoplasms, Experimental 278
paths to the root